CapsoVision Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
99
- Stock Symbol
-
CV
- Share Price
-
$6.29
- (As of Thursday Closing)
CapsoVision General Information
Description
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
Contact Information
Website
www.capsovision.comCorporate Office
- 18805 Cox Avenue
- Suite 250
- Saratoga, CA 95032
- United States
Corporate Office
- 18805 Cox Avenue
- Suite 250
- Saratoga, CA 95032
- United States
CapsoVision Timeline
CapsoVision Stock Performance
As of 12-Nov-2026, CapsoVision’s stock price is $6.29. Its current market cap is $336M with 53.6M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $6.29 | $6.27 | $4.50 - $15.37 | $336M | 53.6M | 168K | -$0.42 |
CapsoVision Financials Summary
As of 30-Sep-2026, CapsoVision has a trailing 12-month revenue of $13.9M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 335,349 | 483,945 | ||
| Revenue | 13,921 | 13,554 | 11,756 | 9,753 |
| EBITDA | (28,878) | (24,993) | (19,392) | (10,955) |
| Net Income | (29,247) | (25,315) | (19,898) | (11,305) |
| Total Assets | 32,752 | 18,164 | 16,803 | 21,527 |
| Total Debt | 780 | 887 | 1,238 | 1,514 |
CapsoVision Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CapsoVision Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
CapsoVision Comparisons
Industry
Financing
Details
CapsoVision Competitors (2)
One of CapsoVision’s 2 competitors is IntroMedic, a Formerly PE-Backed company based in Seoul, South Korea.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| IntroMedic | Formerly PE-Backed | Seoul, South Korea | ||||
| Check-Cap | Formerly VC-backed | Isfiya, Israel |
CapsoVision Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
CapsoVision Patents
CapsoVision Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12648687-B2 | Method and apparatus of adaptive leakage reduction for processor used in a capsule endoscope | Active | 19-Nov-2023 | ||
| US-20250160634-A1 | Method and apparatus of adaptive leakage reduction for processor used in a capsule endoscope | Active | 19-Nov-2023 | ||
| WO-2025053844-A1 | Method and apparatus of automatic detection and deletion of ex vivo images from capsule endoscope | Inactive | 07-Sep-2023 | ||
| US-20240341575-A1 | Intelligent in vivo capsule device with electrodes | Inactive | 13-Apr-2023 | ||
| US-20260224094-A1 | Intelligent in vivo capsule device with electrodes | Pending | 13-Apr-2023 | A61B1/00147 |
CapsoVision Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
CapsoVision ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
CapsoVision FAQs
-
When was CapsoVision founded?
CapsoVision was founded in 2005.
-
Where is CapsoVision headquartered?
CapsoVision is headquartered in Saratoga, CA.
-
What is the size of CapsoVision?
CapsoVision has 99 total employees.
-
What industry is CapsoVision in?
CapsoVision’s primary industry is Diagnostic Equipment.
-
Is CapsoVision a private or public company?
CapsoVision is a Public company.
-
What is CapsoVision’s stock symbol?
The ticker symbol for CapsoVision is CV.
-
What is the current stock price of CapsoVision?
As of 12-Nov-2026 the stock price of CapsoVision is $6.29.
-
What is the current market cap of CapsoVision?
The current market capitalization of CapsoVision is $336M.
-
What is CapsoVision’s current revenue?
The trailing twelve month revenue for CapsoVision is $13.9M.
-
Who are CapsoVision’s competitors?
IntroMedic and Check-Cap are competitors of CapsoVision.
-
What is CapsoVision’s annual earnings per share (EPS)?
CapsoVision’s EPS for 12 months was -$0.42.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
